Browse

Potential role and mechanism of IFN-gamma inducible protein-10 on receptor activator of nuclear factor kappa-B ligand (RANKL) expression in rheumatoid arthritis

DC Field Value Language
dc.contributor.authorLee, Eun Young-
dc.contributor.authorSeo, MiRan-
dc.contributor.authorJuhnn, Yong-Sung-
dc.contributor.authorKim, Jeong Yeon-
dc.contributor.authorHong, Yoo Jin-
dc.contributor.authorLee, Yun Jong-
dc.contributor.authorLee, Eun Bong-
dc.contributor.authorSong, Yeong Wook-
dc.date.accessioned2017-03-21T04:15:41Z-
dc.date.available2017-03-21T14:16:58Z-
dc.date.issued2011-06-27-
dc.identifier.citationArthritis Research & Therapy, 13(3):R104ko_KR
dc.identifier.urihttp://hdl.handle.net/10371/109900-
dc.description.abstractIntroduction
IFN-gamma inducible protein-10 (CXCL10), a member of the CXC chemokine family, and its receptor CXCR3 contribute to the recruitment of T cells from the blood stream into the inflamed joints and have a crucial role in perpetuating inflammation in rheumatoid arthritis (RA) synovial joints. Recently we showed the role of CXCL10 on receptor activator of nuclear factor kappa-B ligand (RANKL) expression in an animal model of RA and suggested the contribution to osteoclastogenesis. We tested the effects of CXCL10 on the expression of RANKL in RA synoviocytes and T cells, and we investigated which subunit of CXCR3 contributes to RANKL expression by CXCL10.

Methods
Synoviocytes derived from RA patients were kept in culture for 24 hours in the presence or absence of TNF-α. CXCL10 expression was measured by reverse transcriptase polymerase chain reaction (RT-PCR) of cultured synoviocytes. Expression of RANKL was measured by RT-PCR and western blot in cultured synoviocytes with or without CXCL10 and also measured in Jurkat/Hut 78 T cells and CD4+ T cells in the presence of CXCL10 or dexamethasone. CXCL10 induced RANKL expression in Jurkat T cells was tested upon the pertussis toxin (PTX), an inhibitor of Gi subunit of G protein coupled receptor (GPCR). The synthetic siRNA for Gαi2 was used to knock down gene expression of respective proteins.

Results
CXCL10 expression in RA synoviocytes was increased by TNF-α. CXCL10 slightly increased RANKL expression in RA synoviocytes, but markedly increased RANKL expression in Jurkat/Hut 78 T cell or CD4+ T cell. CXCL10 augmented the expression of RANKL by 62.6%, and PTX inhibited both basal level of RANKL (from 37.4 ± 16.0 to 18.9 ± 13.0%) and CXCL10-induced RANKL expression in Jurkat T cells (from 100% to 48.6 ± 27.3%). Knock down of Gαi2 by siRNA transfection, which suppressed the basal level of RANKL (from 61.8 ± 17.9% to 31.1 ± 15.9%) and CXCL10-induced RANKL expression (from 100% to 53.1 ± 27.1%) in Jurkat T cells, is consistent with PTX, which inhibited RANKL expression.

Conclusions
CXCL10 increased RANKL expression in CD4+ T cells and it was mediated by Gαi subunits of CXCR3. These results indicate that CXCL10 may have a potential role in osteoclastogenesis of RA synovial tissue and subsequent joint erosion.
ko_KR
dc.language.isoenko_KR
dc.publisherBioMed Centralko_KR
dc.titlePotential role and mechanism of IFN-gamma inducible protein-10 on receptor activator of nuclear factor kappa-B ligand (RANKL) expression in rheumatoid arthritisko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor이은영-
dc.contributor.AlternativeAuthor서미란-
dc.contributor.AlternativeAuthor전용성-
dc.contributor.AlternativeAuthor김정연-
dc.contributor.AlternativeAuthor홍유진-
dc.contributor.AlternativeAuthor이윤정-
dc.contributor.AlternativeAuthor이은봉-
dc.contributor.AlternativeAuthor송영욱-
dc.identifier.doi10.1186/ar3385-
dc.language.rfc3066en-
dc.rights.holderLee et al.; licensee BioMed Central Ltd.-
dc.date.updated2017-01-06T10:47:15Z-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Internal Medicine (내과학전공)Journal Papers (저널논문_내과학전공)
Files in This Item:
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse